ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.77895
-0.01%
Brent Oil
82.39
-0.24%
Bitcoin
61,315.77
0.85%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Edwards Lifesciences Corp (EW)

  7. Edwards Lifesciences Corp (EW) Noticias

EW

Edwards Lifesciences (EW)

Edwards Lifesciences Corp
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:EW
FechaHoraFuenteTítuloSímboloCompañía
10/05/202415:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EWEdwards Lifesciences Corp
09/05/202418:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
09/05/202404:13Business WireEdwards stellt Herzklappenmodell SAPIEN 3 Ultra RESILIA mit Technologie für verbesserte Haltbarkeit in Europa vorNYSE:EWEdwards Lifesciences Corp
09/05/202404:13Business WireEdwards lance la valve SAPIEN 3 Ultra RESILIA en Europe avec une technologie pour améliorer la durabilitéNYSE:EWEdwards Lifesciences Corp
08/05/202418:21Business WireEdwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance DurabilityNYSE:EWEdwards Lifesciences Corp
08/05/202415:52Edgar (US Regulatory)Form 8-K - Current reportNYSE:EWEdwards Lifesciences Corp
07/05/202416:47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
25/04/202415:15Business WireEdwards Lifesciences Reports First Quarter ResultsNYSE:EWEdwards Lifesciences Corp
18/04/202406:10Business WireEdwards Lifesciences to Host Earnings Conference Call on April 25, 2024NYSE:EWEdwards Lifesciences Corp
07/04/202415:30Business WireStudy of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing ItNYSE:EWEdwards Lifesciences Corp
11/03/202413:00Business WireLarge, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVRNYSE:EWEdwards Lifesciences Corp
23/02/202406:05Business WireEdwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare ConferenceNYSE:EWEdwards Lifesciences Corp
12/02/202415:47Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:EWEdwards Lifesciences Corp
06/02/202415:15Business WireEdwards Lifesciences Reports Fourth Quarter ResultsNYSE:EWEdwards Lifesciences Corp
02/02/202406:00Business WireEdwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid ValveNYSE:EWEdwards Lifesciences Corp
30/01/202406:05Business WireEdwards Lifesciences to Host Earnings Conference Call on February 6, 2024NYSE:EWEdwards Lifesciences Corp
25/01/202412:48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:EWEdwards Lifesciences Corp
02/01/202408:00Business WireEdwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:EWEdwards Lifesciences Corp
07/12/202307:30Business WireEdwards Lifesciences Outlines Growth Strategy at Annual Investor ConferenceNYSE:EWEdwards Lifesciences Corp
28/11/202306:06IH Market NewsKeep An Eye Out: Pre-Market Movers And Analyst RecommendationsNYSE:EWEdwards Lifesciences Corp
27/10/202315:49Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:EWEdwards Lifesciences Corp
26/10/202314:06PR Newswire (US)CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATIONNYSE:EWEdwards Lifesciences Corp
26/10/202313:00PR Newswire (US)TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATIONNYSE:EWEdwards Lifesciences Corp
25/10/202315:15PR Newswire (US)EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTSNYSE:EWEdwards Lifesciences Corp
24/10/202313:00PR Newswire (US)FIVE-YEAR DATA FROM PARTNER 3 TRIAL DEMONSTRATE EXCELLENT SURVIVAL FOR PATIENTS RECEIVING EDWARDS SAPIEN 3 VALVENYSE:EWEdwards Lifesciences Corp
19/10/202307:30PR Newswire (US)EDWARDS EVOQUE TRANSCATHETER TRICUSPID VALVE REPLACEMENT SYSTEM RECEIVES CE MARKNYSE:EWEdwards Lifesciences Corp
18/10/202306:05PR Newswire (US)EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 25, 2023NYSE:EWEdwards Lifesciences Corp
08/09/202309:08IH Market NewsKeep An Eye Out: Pre-Market Movers And RecommendationsNYSE:EWEdwards Lifesciences Corp
28/08/202307:10PR Newswire (US)EDWARDS LIFESCIENCES TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCENYSE:EWEdwards Lifesciences Corp
02/08/202310:58Dow Jones NewsCorrection to Edwards Lifesciences 2Q Net Headline on July 26NYSE:EWEdwards Lifesciences Corp
 Showing the most relevant articles for your search:NYSE:EW

Su Consulta Reciente

NYSE
VZ
Verizon Communications
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
SPY
SPDR S&P 500
AMEX
XLV
Health Care Select Sector
USOTC
RHHBY
Roche (QX)
CCOM
US30
US 30
COIN
BTCUSD
Bitcoin
NYSE
CVX
Chevron
CCOM
SILVER
SILVER
COIN
ETHUSD
Ethereum
NYSE
MRK
Merck
FX
EURUSD
Euro vs US Dollar
NASDAQ
MSFT
Microsoft
NASDAQ
AAPL
Apple
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados